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Background. Radial artery (RA) is a useful conduit for coronary artery bypass grafting 
(CABG), but is susceptibility to vasospasm during harvesting. We evaluated the usefulness of 
fasudil, a Rho-kinase inhibitor, in dilating the RA graft and increasing graft free flow compared 
with the conventional graft dilating agents papaverine and verapamil-nitroglycerin.  
Methods. Between June 2012 and January 2013, 45 patients with ischemic heart disease 
who underwent isolated CABG using RA were enrolled and randomly assigned to fasudil 
(n=15), papaverine (n=15), or verapamil-nitroglycerin (n=15) group. Fasudil (0.9 mg/dl), 
papaverine (0.4 mg/ml) mixed with heparinized blood, or verapamil-nitroglycerin was injected 
intraluminally into the RA graft after harvesting. Main outcome measures were RA graft free 
flow, hemodynamic changes, and histopathological examination of RA.  
Results. In the fasudil group, graft free flow increased significantly (p<0.001) from 
36.8±20.4 at baseline to 148.0±88.3 ml/min after injection. Graft free flow increased 
significantly (p<0.001) from 36.0±19.0 to 72.3±36.7 ml/min in the papaverine group, and 
increased significantly (P<0.001) from 39.5 ±23.3 to 64.3 ± 29.9 ml/min in the 
verapamil-nitroglycerin group. The graft free flow was significantly higher (p=0.001) in 
fasudil-treated RA than in papaverine- or verapamil-nitroglycerin-treated RA. 
Histopathologically, RA graft diameter was markedly increased after fasudil injection, and the 
multiple elastic lamellae structure was intact. Blood pressure did not change significantly after 
drug injection in all groups. 
Conclusion. Fasudil exhibited very potent vasodilatory effect on RA compared to 
conventional papaverine or verapamil-nitroglycerin, resulting in increased graft free flow. This 
agent is a useful for dilating RA graft in CABG.  
 





The potential of the radial artery (RA) as an arterial conduit in coronary artery bypass 
grafting (CABG) was first reported in 1973 [1,2]. However, the use of RA in CABG was soon 
abandoned because of vasospasm leading to early occlusion. Later, when long-term potency 
of some RA grafts began to be reported, this graft once again attracted attention and is 
increasingly been used in CABG. The RA graft is an attractive option because it can be 
harvested easily without complications, and endoscopic harvesting is also possible. Apart 
from easy handling, the RA also has other advantages such as being an arterial graft and 
providing a graft of appropriate length. However, RA is still not as widely used as the internal 
thoracic artery. The primary reasons are the high susceptibility of RA graft to vasospasm 
during graft harvesting, which is evident even macroscopically, and the lack of evidence for 
long-term outcome.  
Various vasodilators [3,4] and harvesting techniques [5] have been used to prevent or 
resolve vasospasm of the internal thoracic artery graft, and application of these methods to 
RA graft harvesting has contributed to improve RA graft flow and patency. In this study, we 
investigated the effectiveness of a Rho-kinase inhibitor, fasudil, which is a vasodilator with a 
new mechanism of action. Due to its potent vasodilating action, fasudil has been used 
clinically in the field of neurosurgery to prevent cerebral vasospasm, a serious complication 
secondary to intracranial hemorrhage [6]. Through attenuating coronary spasm, the potential 
of fasudil in the treatment of heart disease and arteriosclerosis is also anticipated [7]. 
Considering the clinical safety and the potent vasodilating action of this drug, we examined 
the usefulness of fasudil as a vasodilating agent for RA graft, as an alternative to 
conventionally used graft dilating agents such as papaverine and verapamil-nitroglycerin (VG) 
solution.  
 





Forty-five consecutive patients who underwent elective CABG using the RA conduit 
between June 2012 and January 2013 in our department were enrolled in this study. Patients 
who had a hemodialysis shunt in the forearm were excluded. The patients were randomly 
assigned according to the agent used to dilate the RA graft into the fasudil group (n=15), VG 
group (n=15) and papaverine group (n=15), by means of a computerized randomization table. 
The trial was approved by the institutional ethics committee (No. 7513). Informed consent was 
obtained from each patient.  
 
Protocol 
Under general anesthesia, RA was isolated together with the accompanying vein by the 
semi-skeletonizing technique using an electric scalpel at settings of Blend 2 and 20 W. After 
administering heparin (150 unit/kg), the graft was transected distally.  
In each group, baseline graft free flow (GFF) of the RA was measured for 60 seconds. 
After 10 min, a graft dilating agent was injected intraluminally into the RA graft. In the fasudil 
group, 2 ml of fasudil solution (Asahi Kasei, Japan) diluted to 0.9 mg/ml (2.67 mmol/L) was 
injected. This concentration was determined according to a basic research that we performed 
previously [8]. In the papaverine group, 2 ml of papaverine (0.4 mg/ml or 1.0 mmol/L) mixed 
with heparinized blood was injected. The concentrations of papaverine varied widely from 30 
μmol/L to 2.6 mmol/L. In the present study, we used the middle concentration of 1.0 mmol/L, 
which is also used in internal thoracic artery grafts [9,10-14]. In the VG group, 2 mL of VG 
solution was injected. The VG solution was composed of 5 mg of verapamil hydrochloride, 2.5 
mg of nitroglycerin, 500 units of heparin and 0.2 mL of 8.4% NaHCO3 in 300 mL of Ringer’s 
solution. This solution gives a concentration of 30 μmol/L each of verapamil and nitroglycerin 
in an isotonic solution at pH 7.4. This concentration was determined based on a previous 
study using VG solution to prepare RA for CABG [15]. Ten minutes after injection of the 
vasodilator, GFF of the RA graft was again measured for 60 seconds.  
Thereafter off-pump CABG was performed in all patients. The total numbers of 
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anastomosis per patient ranged from 2 to 6 (mean, 3.4±1.1). All patients had anastomosis of 
the left anterior descending coronary artery (LAD) with the internal thoracic artery. In addition, 
they had 1-2 anastomoses of the RA (mean 1.1±0.3), and the target vessels were first 
diagonal / obtuse marginal branch, or right coronary artery. 
 
Outcome measures and measurement methods  
Graft free flow of the RA was measured by collecting free flowing blood from the 
transected RA into a special tube and is expressed as mL/min. During GFF measurement, 
mean arterial pressure was measured from the femoral artery and recorded. 
 
Histopathological examination  
Surplus RA tissue of one patient was examined histopathologically. Ring specimens of 
the RA graft stump were collected before and after fasudil injection to examine the 
vasodilating effect. Hematoxylin and eosin (HE) and Elastica van Gieson (EvG) stained 
sections were evaluated qualitatively for changes in the media and elastic fiber, as well as the 
change in diameter. 
 
Statistical analysis 
All statistical analyses were performed using SAS version 9.1.3 (Cary, NC). Continuous 
variables are expressed as mean±standard deviation. The baseline characteristics and 
hospital outcomes for the 3 groups were compared using the Fisher's exact test for categoric 
data or the ANOVA test for continuous data. The fasudil group, papaverine group and VG 
group were compared with respect to pretreatment and posttreatment blood pressure and 






Demographic and hemodynamic data 
The fasudil group (n=15) comprised 12 men and 3 women aged 67.3±9.7 years, while the 
papaverine group (n=15) comprised 11 men and 4 women aged 66.2±11.5 years, and the VG 
group (n=15) comprised 13 men and 2 women aged 69.1±10.1 years, with no significant 
differences among three groups (Table 1). Other demographic data and risk factors of the 
three groups also did not differ significantly (Table 1). 
There were no significant changes in mean arterial pressure among three groups, both 
before and after graft treatment (Table 2). No patient had perioperative myocardial infarction. 
There were no significant differences in the use of inotropic agents and postoperative 
drainage among three groups. No serious complications such as pleural effusion were 
observed, and all patients were discharged after the postoperative observation period.  
 
Effects of fasudil, papaverine and VG 
The GFF of the RA graft treated with fasudil increased significantly (p=0.001) and 
markedly from 36.8±24.0 ml/min at baseline to 148.0±88.3 ml/min at 10 min after treatment 
(Fig. 1). The GFF of the RA graft treated with papaverine increased significantly (p<0.001) 
from 36.0±19.0 ml/min at baseline to 72.3±36.7 ml/min at 10 min after treatment. The GFF of 
the RA graft treated with VG also increased significantly (p<0.001) from 39.5 ± 23.3 ml/min to 
64.3±29.9 ml/min. Comparing fasudil-, papaverine- and VG-treated RA grafts, the 
post-treatment GFF was significantly higher in the fasudil group than in the other two groups 
(both, p < 0.001). 
Graft angiography using 3D-CT was performed in all patients after surgery. All the RA 
grafts in the three groups were patent. 
 
Histopathological findings 
The histopathological findings of ring specimens collected from the RA stump from one 
patient before and after fasudil injection are shown in Fig. 2. The internal diameter was 
increased after fasudil injection. EvG staining showed that the elastic lamella remained intact, 
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To the best of our knowledge, this is the first study that demonstrates that the Rho-kinase 
inhibitor fasudil is effective to prevent RA spasm and consequently increase RA GFF. In the 
present study, fasudil treatment increased RA GFF strikingly by over 400%. These results 
indicate a very potent vasodilatory effect of fasudil for the RA graft. Moreover, intraluminal 
administration of fasudil did not affect the hemodynamic parameters or cause adverse effects, 
which is consistent with previous report in patients with cerebral vasospasm after 
subarachnoid hemorrhage who received fasudil treatment [6]. In the present study the RA 
conduits remained dilated during CABG after short-term fasudil treatment. None of the 15 
patients who underwent grafting of fasudil-treated RA exhibited myocardial ischemia.  
The RA has been positioned as the third arterial graft, after the internal thoracic artery 
and the gastroepiploic artery. However, RA is also known to be very prone to spasm during 
the perioperative period, especially during surgery. This leads to a high rate of early occlusion. 
The evidence is provided by a report indicating that patency is maintained by administering 
calcium antagonist during and after surgery [16]. 
The arteries in humans can be classified into three types according to the structure: type 
1 (somatic), type 2 (splanchnic) and type 3 (limb). RA belongs to type 3, and has been 
reported to be more prone to spasm compared to somatic type arteries such as the internal 
thoracic artery [17,18]. One of the reasons is that RA possesses a smooth muscle-rich media. 
Adequate prevention of perioperative spasm will improve the patency and prevent 
perioperative hemodynamic deterioration, consequently improving long-term outcome. 
Therefore appropriate intraoperative treatment is very important. Surgeons have attempted 
various methods to prevent spasm of the RA graft. One method is to modify the technique of 
harvesting the graft, such as by skeletonization using ultrasonic scalpel. Another is the use of 
vasodilators. Many studies on smooth muscle relaxation with various drugs have been 
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conducted using in vivo RA segments. These vasodilators can be classified as follows.  
Nitrates and nitrate derivatives. This class of agents includes glycerin trinitrate, isosorbide 
dinitrate, sodium nitroprusside and nicorandil. All have been shown to possess vasodilatory 
effect, and increase of GFF including that of RA graft has been reported [19]. The increase is 
in the magnitude of 24 to 32 ml/min, and increase of over 100% has not been reported. The 
vasodilatory effect of nitrates on RA segments has been reported by Chanda et al [16] and He 
et al [20]. 
Calcium channel blockers. This class of drugs is the most frequently used vasodilator, 
because they act by selectively blocking L type voltage-operated calcium channels on smooth 
muscle cell membrane, thereby inhibiting calcium influx and attenuating the contractile 
response [21]. The usefulness of verapamil has also been proven experimentally, but many 
studies used a combination with nitrate. A cocktail of verapamil and nitroglycerin (VG solution) 
has been extensively studied. He and Yang [15] and Dogan et al [22] reported good 
vasodilatory effect for RA. Yoshizaki et al [23] also reported that VG solution is a superior 
vasodilator based on postoperative imaging studies. The present study showed that 
intraluminal injection of VG solution into the RA graft significantly increased GFF, but the 
magnitude of increase was only moderate. A reason for this finding is the difference in 
treatment method used. He [24] immersed the RA grafts in the VG solution for 30 min as soon 
as they were dissected, while we injected VG solution intraluminally and waited for only 10 
min. Our method probably did not allow maximal action of VG solution on the RA graft.  
Phosphodiesterase inhibitors. PDE inhibitors have been used in recent years. Na et al [25] 
observed increase in GFF both in RA and internal thoracic artery, with an increase from 91 to 
110 ml/min in RA. The anti-spasm effect was also observed in segment specimens [26,27], 
but superiority to VG solution has not been reported. Papaverine is one of the most commonly 
used vasodilators for arterial graft. It is a benzylisoquinonline alkaloid with non-selective 
smooth muscle relaxant properties [28]. Although papaverine is a low-cost drug exhibiting 
vasodilating effect for internal thoracic artery, evaluation of its effect has been variable [29]. In 
addition, being an acidic solution, there is a risk of endothelial damage [30].  
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Although the drugs described above have been shown to be effective to certain extent, 
none of the reports indicated an increase in GFF by over 100%. The VG solution is the most 
commonly used vasodilator [24], but the development of more effective and safe vasodilator 
for RA graft has been awaited. 
Rho kinase is an intracellular serine/threonine kinase identified in the mid-1990s as the 
target protein for the low molecular weight GTP-binding protein “Rho” [31-33]. Rho kinase is 
closely related to many physiological functions such as contraction, cell proliferation, cell 
migration, and induction of gene expression. Rho kinase is known to regulate vascular 
smooth muscle contraction and relaxation independent of the intracellular calcium ion 
concentration. Rho kinase is also implicated in endothelial dysfunction, which includes 
inhibition of nitric oxide synthase, upregulation of leukocyte adhesion molecule expression, 
and upregulation of proinflammatory cytokine expression [34]. Therefore fasudil might protect 
endothelium from damage, thereby preventing intimal proliferation, acceleration of 
atherosclerosis and thrombosis, which likely improves the long-term patency of grafts. Our 
previous study [8] suggested that the antispastic effect of fasudil is due to blockade 
of Rho-associated protein kinase (ROCK), because intraluminal fasudil injection into RA 
abolishes the increase in myosin phosphatase targeting subunit 1 (MYPT1) phosphorylation 
at the ROCK phosphorylation site Thr853, and consequently deinhibits myosin light chain 
phosphatase. 
In patients with coronary vasospastic angina, selective injection of the Rho kinase 
inhibitor fasudil into the coronary artery inhibited acetylcholine-provoked coronary vasospasm, 
angina-related ECG change and chest pain [35]. In patients with intractable coronary 
vasospasm after CABG not responding to maximum vasodilatory therapy, fasudil treatment 
markedly ameliorated the condition [36]. With the objective to apply the potent vasodilatory 
effect of Rho kinase inhibitor to CABG, we performed a study to investigate the in situ 
vasodilatory effect of fasudil on human internal thoracic artery, and showed superior 
vasodilating effect of fasudil compared to papaverine [9]. In the present study, we found that 




The method of administering vasodilatory agent during CABG is an important issue. From 
the mechanism of action of the drug, three methods are plausible: (1) intraluminal injection; 
(2) topical application on the adventitia or covering with gauze soaked with the drug; and (3) 
systemic administration. For RA, the drug and the administration method that provide 
maximum effectiveness remain unknown and the exact mechanism is also unclear. In the 
present study, to exclude the effect of drug infiltration from outside and the effect of systemic 
administration, we injected a small volume (2 ml) of fasudil intraluminally. Because of the 
small volume, the drug is unlikely to circulate systemically. Hence we evaluated only the effect 
of intraluminal administration. Studies on the effects of topical application and systemic 
administration are ongoing. Fasudil is a relatively low cost drug and has a long history of 
clinical use. The performance of this drug in the neurosurgical field has been documented for 
over 10 years [6]. Therefore fasudil can be used without concern over safety.  
   CABG using an adequately dilated RA may yield good flow from immediately after surgery. 
Since our studies have demonstrated that fasudil is a superior graft vasodilator for both 
internal thoracic artery [9] and RA, this agent may become the standard for arterial graft 
pretreatment in CABG. 
 
Conclusion 
    Fasudil has very potent vasodilatory effect on RA, resulting is significantly increased GFF. 
The vasodilatory effect is confirmed by histopathological finding. Fasudil is a very effective 
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Fig. 1. Change in graft free flow (mL/min) of radial artery graft before and after treatment with 
fasudil, papaverine or verapamil-nitroglycerin solution. Data are expressed as mean (point) ± 
standard deviation error (bar). 
 
Fig. 2. Histopathologic findings of radial artery specimen before fasudil injection (A) and after 
fasudil injection (B). Elastica van Gieson staining. The diameter of the radial artery increases 









Papaverine        
(n=15) 
VG solution        
(n=15) 
ANOVA 
Age; years (mean±SD) 67.3±9.7 66.2±11.5 69.1±10.1 NS 
Male; number (%) 12 (80%) 11 (73%) 12 (80%) NS 
Diabetes mellitus; number (%) 5 (33%) 6 (40%) 6 (40%) NS 
Hypertension; number (%) 5 (33%) 6 (40%) 5 (33%) NS 
Hypercholesterolemia; number (%) 8 (53%) 10 (67%) 9 (60%) NS 
Smoking; number (%) 3 (20%) 3 (20%) 4 (27%) NS 
LVEF <35%; number (%) 6 (40%) 5 (33%) 6 (40%) NS 
Preoperative renal failure; number 0  0  0  NS 
Prior coronary surgery; number 0  0  0  NS 
Left main disease; number (%) 4 (27%) 5 (33%) 4 (27%) NS 
 
VG solution: verapamil-nitroglycerin, LVEF: left ventricular ejection fraction, NS: not significant 
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Table 2. Comparison of mean blood pressure before and after treatment of radial artery graft 
with fasudil, papaverine or verapamil-nitroglycerin (VG solution) 
    
Fasudil              
(n = 15) 
Papaverine        
(n = 15) 
VG solution        
(n = 15) 
p value         
ANOVA 
Blood pressure (mmHg) (mean±SD) 
     Pretreatment 
 
65.1± 9.9 65.0 ±10.7 66.0 ± 8.8 
0.492  
     Posttreatment   64.4± 9.3 68.1±12.6 65.5± 9.9 
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